Exploring Motor Learning in Acute Stroke Through Robotics

NCT ID: NCT04171856

Last Updated: 2025-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

245 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-01

Study Completion Date

2040-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The acute phase of stroke is characterized by an enhancement of neural plasticity which supports rapid motor recovery. It is unclear whether acute stroke patients can acquire new motor skills with their affected upper limb. The aims of this research program are:

1. To test the capacity of acute stroke patients (\< 21 days) to learn and retain a complex unimanual motor skill.
2. To explore whether acute stroke to different brain regions (quantified with brain MRI) induces specific deficits in motor skill learning.
3. To compare acute stroke patients with healthy individuals and with chronic stroke patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Over 3 consecutive days, the subjects will be evaluated and will train on the rehabilitation robot REAplan® (http://www.axinesis.com/). They will practice 2 serious games on the robot.

In order to differentiate the effect of motor control recovery from that of MskL, the acute stroke patients will be randomised 4/1 to "MskL" (n=120) ,to "motor control recovery" (n=30) or to "conventional" group (n=15) with a minimisation software. The experimental design will be similar except that the "motor control recovery" group will practice the serious game EASY instead of CIRCUIT (see below) and the "conventional" group will practice conventional therapy instead of CIRCUIT. The performances on both EASY \& CIRCUIT will be compared between groups (subjects in both groups will perform the EASY \& CIRCUIT tasks).The total time of rehabilitation will be the same.

The motor skill learning setup (CIRCUIT + EASY) that we developed and successfully used in healthy individuals and stroke patients has already been implemented in the REAplan environment and will be used as innovative serious games based on a speed/accuracy trade-off (SAT), allowing a detailed analysis of motor skill learning components (speed, accuracy, SAT, movement smoothness, dynamics...). For the serious game CIRCUIT, who based on motor skill learning, the subjects will have to practice a complex circuit and move as a cursor quickly and accurately as possible by controlling the handle of the robot with their affected hand/arm. For the other task EASY (a brick busters serious game), the aim will be to go back and forth between walls presented in different locations. The CONVENTIONAL therapy will consist in classical exercices focused in the upper limb administered by occupational therapist.

The subacute stroke phase is a unique opportunity to investigate the role of brain structures in motor learning/control. Compared to chronic impairments (\> 6 months post-stroke), the subacute phase provides a window into how a lesion perturbs sensorimotor functions prior to reorganisation driven by plasticity and neurorehabilitation. To clarify the role of different brain structures in MskL, Voxel-based Lesion Symptom Mapping (VLSM) based on high-resolution brain magnetic resonance imaging (MRI) scans, will be used to analyse the relationship between tissue damage and MskL scores on a voxel-by-voxel basis.

In addition, several "classical" clinical scales and tests will be used to evaluate overall motor-sensory-cognitive functions. The subjects will practice serious games on the robot REAplan (R), requiring movements with the affected arm (unimanual tasks).

And, we used a Dextrain® tool which allows quantification of key components of manual dexterity : forces, selectivity (independance of fingers movement) and coactivation of the fingers.Moreover, we added a Transcranial magnetic stimulation (TMS), as a tool for predicting recovery of motor function after stroke.

In addition to the (sub)acute stroke patients, 4 others groups will be recruited for this study : a group of acute stroke patients who will receive "conventional rehabilitation" and be shortly tested on the robot (N=15), a group of chronic stroke patients (stroke \> 6 months) who will not be hospitalized and will not undergo MRI (N=30), a group of healthy individuals who will not undergo MRI (N=50) and a group of patients with a transient global amnesia which is a sudden, temporary episode (\<24hours) of memory loss (N=15).

Subjects in these 4 groups will be randomized 1/1 in the two arms ("MSkL" versus "motor control recovery" arms), except the patients with a TGA who will be included in the "MSkL" arm only.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke, Acute

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Motor Skill Learning (CIRCUIT)

Intervention: training on the REAplan robot with a serious game based on motor skill learning (MSkL) serious game, the CIRCUIT.

Group Type EXPERIMENTAL

REAplan(R)

Intervention Type DEVICE

motor skill learning with the REAplan(R) rehabilitation robot, to be perfomed with the affected arm

Motor control recovery (EASY)

Training on the REAplan robot with a serious game that requires similar type and amount of movements but does not rely on motor skill learning (EASY), a brick buster game.

Group Type ACTIVE_COMPARATOR

REAplan(R)

Intervention Type DEVICE

motor skill learning with the REAplan(R) rehabilitation robot, to be perfomed with the affected arm

Conventional

Training sessions with classical exercices focused on the upper limb administered by occupation therapist.

Group Type ACTIVE_COMPARATOR

REAplan(R)

Intervention Type DEVICE

motor skill learning with the REAplan(R) rehabilitation robot, to be perfomed with the affected arm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

REAplan(R)

motor skill learning with the REAplan(R) rehabilitation robot, to be perfomed with the affected arm

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* acute stroke (\> 21 days)
* aged 18-90 years
* with a stroke lesion on brain imaging


* Transient global amnesia
* 8-90 years old
* Be able to perform 3 consecutive sessions on a rehabilitation robot


• 18-90 years


* chronic stroke (\>6 months)
* aged 18-90 years
* with a stroke lesion on brain imaging

Exclusion Criteria

* " classical " contre-indication to MRI (non-MR-compatible pacemaker, pregnancy, non-MR-compatible implanted devices, claustrophoby, etc ...)
* difficulty in understanding or executing commands
* drug/alcohol abuse
* severe aphasia / cognitive deficits interfering with study
* inability to voluntarily move the affected arm (i.e. complete paralysis of the arm)
* multiple strokes / dementia / psychiatric condition

PATIENTS WITH TRANSIENT GLOBAL AMNESIA:

Clinical diagnosis, criteria of Hodge \& Warlow (1990):

* Anterograde amnesia observed by a witness
* No alteration of consciousness or loss of identity
* Cognitive dysfunction limited to amnesia
* Lack of focused neurological deficit or argument for a comitiality
* Absence of head trauma
* Symptom resolution within 24 hours
* Possible existence of vegetative symptoms


* Severe aphasia / cognitive deficits interfering with study
* Psychiatric disorders
* Alcohol / drug addiction

HEALTHY INDIVIDUALS:


* medical history with a previous stroke/neurological deficit
* drug/alcohol abuse
* psychiatric condition/ dementia

CHRONIC STROKE PATIENTS:


* difficulty in understanding or executing commands
* drug/alcohol abuse
* severe aphasia / cognitive deficits interfering with study
* inability to voluntarily move the affected arm (i.e. complete paralysis of the arm)
* multiple strokes / dementia / psychiatric condition
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital of Mont-Godinne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pr Yves Vandermeeren, MD, PhD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yves Vandermeeren, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

UCLouvain IONS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU UCL Namur

Yvoir, Namur, Belgium

Site Status RECRUITING

University Hospital CHU Dinant Godinne UCL

Yvoir, , Belgium

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yves Vandermeeren, MD, PhD

Role: CONTACT

+32 81 42 33 21

Eloïse Gerardin, MSc

Role: CONTACT

+32 81 42 33 48

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Eloïse Gerardin

Role: primary

+3281423348

Yves Vandermeeren, MD, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B039201938990

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Robot Assisted Neuro-Rehabilitation
NCT01253018 COMPLETED PHASE1/PHASE2
Robotic Rehabilitation for Stroke Survivors
NCT05417828 NOT_YET_RECRUITING